SH-SY5Y cells as a model for sigma receptor regulation of potassium- stimulated dopamine release

Brain Research

Volumn 877, Issue 2, 2000, Pages 354-360

  Ault, David T ^a   Werling, Linda L ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

(+) Pentazocine; Dopamine; NPY; SH SY5Y; Sigma receptor

Indexed keywords

DOPAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (1 PYRROLIDINYL)CYCLOHEXYLAMINE; NEUROPEPTIDE Y; OPIATE ANTAGONIST; PENTAZOCINE; POTASSIUM; SIGMA OPIATE RECEPTOR;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANALGESICS, OPIOID; ANIMAL; CYCLOHEXYLAMINES; DOPAMINE; DRUG INTERACTIONS; HUMAN; MODELS, NEUROLOGICAL; NARCOTIC ANTAGONISTS; NEUROBLASTOMA; NEUROPEPTIDE Y; PENTAZOCINE; POTASSIUM; PYRROLIDINES; RECEPTORS, SIGMA; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0034703456     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02722-0     Document Type: Article

References (27)

1. 3H]dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor. J. Pharmacol. Exp. Ther. 284:1998;553-560.
2. 3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands. Brain Res. 760:1997;210-217.
3. 3H]dopamine release from rat prefrontal cortex is reversed by sigma1 receptor antagonists. Schizophr. Res. 31:1998;27-36.
4. Ault D.T., Werling L.L. Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors. Eur. J. Pharmacol. 386:1999;145-153.
5. Cassarino D.S., Fall C.P., Smith T.S., Bennett J.P. Jr. Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion. J. Neurochem. 71:1998;295-301.
6. Connor M., Henderson G. Delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 117:1996;333-340.
7. Connor M., Yeo A., Henderson G. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 120:1997;455-463.
8. Fang J., Zuo D., Yu P.H. Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells. Psychopharmacology, Berl. 121:1995;373-378.
9. 3H]dopamine release from rat striatal slices by sigma receptor ligands. J. Pharmacol. Exp. Ther. 271:1994;212-219.
10. Hong W., Werling L.L. Binding of sigma 1 receptor ligands and their effects on intracellular calcium in SH-SY5Y cells. Soc. Neurosci. Abstr. 25:1999;1475.
11. Ishigami S., Werling L.L. Steroids compete for haloperidol binding at sigma receptors on SH-SY5Y cells. Soc. Neurosci. Abstr. 25:1999;1475.
12. Maruyama W., Naoi M., Kasamatsu T., Hashizume Y., Takahashi T., Kohda K., Dostert P. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells. J. Neurochem. 69:1997;322-329.
13. 2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue. Neuropharmacology. 34:1995;1507-1514.
14. 3H]noradrenaline from human neuroblastoma cells, SH-SY5Y. J. Neurochem. 56:1991;1810-1815.
15. Oh-hashi K., Maruyama W., Yi H., Takahashi T., Naoi M., Isobe K. Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. Biochem. Biophys. Res. Commun. 263:1999;504-509.
16. Ou X.M., Partoens P.M., Wang J.M., Walker J.H., Danks K., Vaughan P.F., De Potter W.P. The storage of noradrenaline, neuropeptide Y and chromogranins in and stoichiometric release from large dense cored vesicles of the undifferentiated human neuroblastoma cell line SH-SY5Y. Int. J. Mol. Med. 1:1998;105-112.
17. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Analyt. Biochem. 83:1977;346-356.
18. 3H] noradrenaline from SH-SY5Y cells. J. Neurochem. 64:1995;1175-1182.
19. Ross R.A., Biedler J.L. Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro. Cancer Res. 45:1985;1628-1632.
20. Ross R.A., Spengler B.A., Biedler J.L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71:1983;741-747.
21. Seward E., Hammond C., Henderson G. Mu-opioid-receptor-mediated inhibition of the N-type calcium-channel current. Proc. R. Soc. Lond. B Biol. Sci. 244:1991;129-135.
22. Seward E.P., Henderson G. Characterization of two components of the N-like, high-threshold-activated calcium channel current in differentiated SH-SY5Y cells. Pflügers Arch. 417:1990;223-230.
23. Sheehan J.P., Palmer P.E., Helm G.A., Tuttle J.B. MPP+ induced apoptotic cell death in SH-SY5Y neuroblastoma cells: an electron microscope study. J. Neurosci. Res. 48:1997;226-237.
24. Takahashi T., Deng Y., Maruyama W., Dostert P., Kawai M., Naoi M. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J. Neural Transm. Gen. Sect. 98:1994;107-118.
25. Vaughan P.F., Kaye D.F., Reeve H.L., Ball S.G., Peers C. Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y. J. Neurochem. 60:1993;2159-2166.
26. Vilner B.J., John C.S., Bowen W.D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 55:1995;408-413.
27. Wahlestedt C., Regunathan S., Reis D.J. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. Life Sci. 50:1992;PL7-PL12.